Southern Cancer Center

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Lung cancer3 trials
• Diffuse large B-cell lymphoma1 trial
• Kidney cancer1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 34 trials
• Phase 22 trials

Status

• Active, not recruiting2 trials
• Completed2 trials
• Recruiting2 trials

Lead sponsor

• Hoffmann-La Roche2 trials
• Pfizer2 trials
• Puma Biotechnology, Inc.1 trial
• SCRI Development Innovations, LLC1 trial

Running trials

• Recruiting

  A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

  NCT07144280· Phase 3· Pfizer· Source

• Active, not recruiting

  BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

  NCT06773910· Phase 2· SCRI Development Innovations, LLC· Source

• Recruiting

  A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

  NCT06095505· Phase 2· Puma Biotechnology, Inc.· Source

  Contact: Puma Biotechnology, Inc. Clinical Operations Senior Director

• Active, not recruiting

  A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

  NCT06065748· Phase 3· Hoffmann-La Roche· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer2 recruiting

Closed trials

• Completed

  A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma

  NCT03274492· Phase 3· Hoffmann-La Roche· Source

• Completed

  A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)

  NCT02684006· Phase 3· Pfizer· Source